Libo Pharma Corp. (TPEX:7888)
Taiwan
· Delayed Price · Currency is TWD 40.90
+0.10 (0.25%)
At close: Apr 28, 2026
Libo Pharma Market Cap
Libo Pharma has a market cap or net worth of 3.08 billion as of April 28, 2026.
Market Cap
3.08B
Enterprise Value
2.28B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
40.90
Market Cap Chart
Since December 23, 2025, Libo Pharma's market cap has decreased from 3.55B to 3.08B, a decrease of -13.26%. That is a compound annual growth rate of -33.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 3.08B | -16.87% |
| Dec 31, 2025 | 3.70B | 4.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Yoda Pharmaceuticals | 3.60B |
| Protect Animal Health | 2.19B |
| TEH SENG Pharmaceutical Mfg. | 1.96B |
| TSA International | 1.93B |
| Timing Pharmaceutial | 1.80B |
| Gin Hwa Biotech Incorporation | 1.80B |
| Taho Pharmaceuticals | 6.19B |
| Anya Biopharm | 1.51B |